KALA BIO, INC. Shareholders' Equity
KALA BIO, INC. (KALA) had Shareholders' Equity of $9.04 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-19
- 2026-06-30: Stockholders' Equity Attributable to Parent $9.04M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.76M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.00M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$8.66M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $9.04M 10-Q · filed 2026-08-19 |
| 2026-03-31 | $10.76M 10-Q · filed 2026-08-19 |
| 2025-12-31 | $7.00M 10-Q · filed 2026-08-19 |
| 2025-09-30 | -$8.66M 10-Q · filed 2025-11-19 |
| 2025-06-30 | -$3.21M 10-Q · filed 2026-08-19 |
| 2025-03-31 | $5.71M 10-Q · filed 2026-08-19 |
| 2024-12-31 | $12.33M 10-Q · filed 2026-08-19 |
| 2024-09-30 | $6.86M 10-Q · filed 2025-11-19 |
| 2024-06-30 | $13.72M 10-Q · filed 2025-11-19 |
| 2024-03-31 | $6.66M 10-Q · filed 2025-08-08 |
| 2023-12-31 | $7.50M 10-K · filed 2026-04-15 |
| 2023-09-30 | $11.22M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $17.49M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $23.46M 10-Q · filed 2024-08-06 |
| 2022-12-31 | $18.97M 10-K · filed 2025-03-31 |
| 2022-09-30 | -$968.00K 10-Q · filed 2023-11-13 |
| 2022-06-30 | -$31.55M 10-Q · filed 2023-11-13 |
| 2022-03-31 | -$5.28M 10-Q · filed 2023-08-04 |
| 2021-12-31 | $16.80M 10-K · filed 2024-03-29 |
| 2021-09-30 | $61.47M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $84.27M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $109.79M 10-Q · filed 2022-08-11 |
| 2020-12-31 | $100.00M 10-K · filed 2023-03-03 |
| 2020-09-30 | $106.03M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $128.94M 10-Q · filed 2021-11-15 |
| 2020-03-31 | $141.51M 10-Q · filed 2021-08-05 |
| 2019-12-31 | $29.69M 10-K · filed 2022-03-29 |
| 2019-09-30 | $43.06M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $61.07M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $82.37M 10-Q · filed 2020-08-06 |
| 2018-12-31 | $104.98M 10-K · filed 2021-02-25 |
| 2018-09-30 | $54.93M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $68.09M 10-Q · filed 2019-11-07 |
| 2018-03-31 | $80.27M 10-Q · filed 2019-08-06 |
| 2017-12-31 | $89.68M 10-K · filed 2020-02-12 |
| 2017-09-30 | $98.86M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$107.42M 10-Q · filed 2017-08-31 |
| 2016-12-31 | -$87.76M 10-K · filed 2019-03-12 |
| 2015-12-31 | -$56.66M 10-K · filed 2018-04-02 |
| 2014-12-31 | -$40.72M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |